4.7 Article

Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment

期刊

LIVER INTERNATIONAL
卷 42, 期 8, 页码 1772-1782

出版社

WILEY
DOI: 10.1111/liv.15324

关键词

clinical practice gaps; continuing professional development continuing medical education; needs assessment; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis

资金

  1. Pfizer
  2. International Atherosclerosis Society (IAS)
  3. National Institute for Health research (NIHR) Oxford Biomedical Research Centre (BRC)

向作者/读者索取更多资源

When managing patients with NASH, healthcare professionals face challenges in collaborating with primary care, lack familiarity with relevant blood markers and diagnostic methods, and have knowledge and skill gaps in managing comorbidities and facilitating patient lifestyle changes.
Background and aims Even as several pharmacological treatments for non-alcoholic steatohepatitis (NASH) are in development, the incidence of NASH is increasing on an international scale. We aim to assess clinical practice gaps and challenges of hepatologists and endocrinologists when managing patients with NASH in four countries (Germany/Italy/United Kingdom/United States) to inform educational interventions. Methods A sequential mixed-method design was used: qualitative semi-structured interviews followed by quantitative online surveys. Participants were hepatologists and endocrinologists practising in one of the targeted countries. Interview data underwent thematic analysis and survey data were analysed with chi-square and Kruskal-Wallis tests. Results Most interviewees (n = 24) and surveyed participants (89% of n = 224) agreed that primary care must be involved in screening for NASH, yet many faced challenges involving and collaborating with them. Endocrinologists reported low knowledge of which blood markers to use when suspecting NASH (56%), when to order an MRI (65%) or ultrasound/FibroScan (R) (46%), and reported sub-optimal skills interpreting alanine aminotransferase (ALT, 37%) and aspartate aminotransferase (AST, 38%) blood marker test results, causing difficulty during diagnosis. Participants believed that more evidence is needed for upcoming therapeutic agents; yet, they reported sub-optimal knowledge of eligibility criteria for clinical trials. Knowledge and skill gaps when managing comorbidities, as well as skill gaps facilitating patient lifestyle changes were reported. Conclusions Educational interventions are needed to address the knowledge and skill gaps identified and to develop strategies to optimize patient care, which include implementing relevant care pathways, encouraging referrals and testing, and multidisciplinary collaboration, as suggested by the recent Global Consensus statement on NAFLD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据